v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss from operations $ (3,756,479) $ (2,748,874)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 498
Amortization expense 1,175,726 667,883
Gain recognized on common stock issued to settle liability 79,591
Loss recognized on Aibotics common stock issued to settle liability 91,248
Amortization of debt discount 16,973 9,350
Changes in operating assets and liabilities:    
Prepaid expense 35,833
Accounts payable and accrued expenses 2,004,497 1,455,145
Accrued expenses - related party 168,000 288,000
NET CASH USED IN OPERATING ACTIVITIES (264,202) (248,407)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from convertible note payable 300,000
Repayments of convertible note payable (50,000)
NET CASH PROVIDED BY FINANCING ACTIVITIES 250,000
Effect of exchange rate on cash (27,491) 48,886
Net decrease in cash (41,693) (199,521)
Cash, beginning of year 833,125 1,032,646
Cash, end of year 791,432 833,125
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Common stock issued in settlement of settle accounts payable and accrued expenses 250,000 477,417
Issuance of common stock upon conversion of convertible notes payable and accrued interest 223,435
Issuance of common stock for intangible assets 2,800,000
Common stock issued to settle accounts payable and accrued expenses 363,166
Common stock issued to settle accrued expenses – related party 225,000
Issuance of common stock in exchange for consulting services 50,000
Common stock issued for cash and settlement of accrued interest, net of issuance costs 968,121
Shares to be issued 44,000
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest
Cash paid for income taxes